Most Recent
Domain has sued News Corp-owned rival REA Group over alleged misleading claims that it attracts the buyer for nine in 10 sold homes listed on the platform.
The competition regulator has opposed Coles Group's proposed acquisition of a leasehold interest in a Kalgoorlie supermarket and liquor store site, finding it would substantially lessen competition in the retail supply of groceries in the region.
A judge has found that ASIC's case against WA gold mining company Wiluna over alleged omissions in a 2022 ASX announcement should await the determination of related cases against two executives, citing the risk of inconsistent findings.
The ACCC has opened a phase 2 review of calibration and asset management services provider Trescal's proposed acquisition of TechRentals Calibration & Sales after identifying potential risks to competition.
ASIC has won its case alleging Regional Express failed to correct an optimistic forecast before it entered administration last year, but failed to prove the company's optimism conveyed a "likelihood" or that three non-executive directors had actual knowledge of the collapsed budget airline's declining business.
The consumer regulator has brought proceedings against Amazon, alleging it relied on unfair contract terms in its Prime Video subscription contracts to introduce advertising to its streaming service.
A parliamentary committee has called on the ACCC to investigate Apple's digital payments market power, finding that the sector is "anti-competitive, opaque and complex".
Defence lawyers are bracing for a wave of class actions over companies’ use of generative artificial intelligence, with privacy, discrimination, consumer, product liability and shareholder claims expected.
Online retailer HSK United has agreed to pay two infringement notices totaling $79,200 after the consumer watchdog alleged its websites Pain Free Aussies and Modern Aussies contained misleading pricing and returns information.
A class action against Johnson & Johnson over alleged ineffective cold medicine has attacked the pharmaceutical company’s application for soft class closure, telling a court the process would produce useless data and only need to be repeated.